Skip to main content
Back to feed
MarketsReportedLow
2.1

Orexo announces 250M SEK rights issue, diluting existing shareholders

Swedish pharma Orexo plans a 250M SEK rights issue, half its market cap, signaling capital needs likely for R&D or debt. The move dilutes existing shareholders, reflecting financial strain or strategic investment. Market reaction uncertain pending terms.

Dagens Industri2 days agoSECredibility 28%View source

Score Breakdown

Mosaic Score2.1
Model confidence0.9
Significance0.1
Source credibility0.3

Intelligence Tags

#rights issue#equity financing#pharmaceutical#sweden

Entities

country
Source

Related signals

8 found